ALBT — AVALON GLOBOCARE CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About AVALON GLOBOCARE CORP (ALBT)
AVALON GLOBOCARE CORP (ALBT) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $29,845. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ALBT
How many top investors track ALBT
Only 1 tracked investor report this position.
ALBT Ownership Composition
How AVALON GLOBOCARE CORP is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ALBT
- Ken GriffinMar 31, 2026Citadel AdvisorsShares56.2KValue$29.8K% Portfolio0.00%
Recent activity
- New$29.8KMay 15, 2026
Frequently asked questions
- How many institutional investors hold ALBT?
- 1 tracked institutional investor disclosed a position in ALBT (AVALON GLOBOCARE CORP) in their most recent 13F filing.
- Who is the largest institutional holder of ALBT?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ALBT, valued at $29,845.
- Did institutional ownership of ALBT increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited ALBT.
- Where does this ALBT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.